These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23283830)

  • 21. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traditional Methods versus Quantitative Sensory Testing of the Feet at Risk: Results from the Rotterdam Diabetic Foot Study.
    Rinkel WD; Castro Cabezas M; Setyo JH; Van Neck JW; Coert JH
    Plast Reconstr Surg; 2017 Mar; 139(3):752e-763e. PubMed ID: 28234858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
    Oyer DS; Saxon D; Shah A
    Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel robotic monofilament test for diabetic neuropathy.
    Wilasrusmee C; Suthakorn J; Guerineau C; Itsarachaiyot Y; Sa-Ing V; Proprom N; Lertsithichai P; Jirasisrithum S; Kittur D
    Asian J Surg; 2010 Oct; 33(4):193-8. PubMed ID: 21377106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous angiocatheters as a novel alternative to Semmes-Weinstein monofilament evaluation in testing protective sensation.
    Hire JM; Ramadorai UE; Contractor D; Jacobs JM; Bojescul JA; Abell BE
    Mil Med; 2014 Apr; 179(4):442-4. PubMed ID: 24690970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Semmes-Weinstein 5.07/10 gram monofilament: the long and the short of it.
    McGill M; Molyneaux L; Yue DK
    Diabet Med; 1998 Jul; 15(7):615-7. PubMed ID: 9686703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathic and ischemic changes of the foot in Brazilian patients with diabetes.
    Muniz EC; Rocha RM; Reis ML; Santos VL; Grossi SA
    Ostomy Wound Manage; 2003 Aug; 49(8):60-70, 72-3. PubMed ID: 14631664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy.
    Sosenko JM; Sparling YH; Hu D; Welty T; Howard BV; Lee E; Robbins DC
    Diabetes Care; 1999 Oct; 22(10):1715-21. PubMed ID: 10526741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy.
    Lee S; Kim H; Choi S; Park Y; Kim Y; Cho B
    J Korean Med Sci; 2003 Feb; 18(1):103-7. PubMed ID: 12589096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved sensitivity in patients with peripheral neuropathy: effects of monochromatic infrared photo energy.
    DeLellis SL; Carnegie DH; Burke TJ
    J Am Podiatr Med Assoc; 2005; 95(2):143-7. PubMed ID: 15778471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of monofilament in the detection of foot lesions in older adults.
    Modawal A; Fley J; Shukla R; Rudawsky D; Welge J; Yang J
    J Foot Ankle Surg; 2006; 45(2):76-81. PubMed ID: 16513501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
    Armstrong DG; Hussain SK; Middleton J; Peters EJ; Wunderlich RP; Lavery LA
    Ostomy Wound Manage; 1998 May; 44(5):70-4, 76. PubMed ID: 9697548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy--MIRE.
    Harkless LB; DeLellis S; Carnegie DH; Burke TJ
    J Diabetes Complications; 2006; 20(2):81-7. PubMed ID: 16504836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes.
    Olmos PR; Cataland S; O'Dorisio TM; Casey CA; Smead WL; Simon SR
    Am J Med Sci; 1995 Feb; 309(2):76-82. PubMed ID: 7847445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic reversal of peripheral neuropathy in patients with diabetes.
    Kochman AB; Carnegie DH; Burke TJ
    J Am Podiatr Med Assoc; 2002 Mar; 92(3):125-30. PubMed ID: 11904323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel plantar stimulation technology for improving protective sensation and postural control in patients with diabetic peripheral neuropathy: a double-blinded, randomized study.
    Najafi B; Crews RT; Wrobel JS
    Gerontology; 2013; 59(5):473-80. PubMed ID: 23860103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of diabetic peripheral neuropathy and new wound incidence: the role of MIRE.
    Powell MW; Carnegie DE; Burke TJ
    Adv Skin Wound Care; 2004; 17(6):295-300. PubMed ID: 15289717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy and durability of Semmes-Weinstein monofilaments: what is the useful service life?
    Lavery LA; Lavery DE; Lavery DC; Lafontaine J; Bharara M; Najafi B
    Diabetes Res Clin Pract; 2012 Sep; 97(3):399-404. PubMed ID: 22560793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
    Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of Vibro-medical insole on vibrotactile sensation in diabetic patients with mild-to-moderate peripheral neuropathy.
    Bagherzadeh Cham M; Mohseni-Bandpei MA; Bahramizadeh M; Kalbasi S; Biglarian A
    Neurol Sci; 2018 Jun; 39(6):1079-1084. PubMed ID: 29594830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.